![Open Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltextgreen.png)
![Restricted Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltextred.png)
![Open Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltextgreen.png)
![Open Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltext_open_medium.gif)
![Restricted Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltextred.png)
![Restricted Access](https://i-scholar.in/lib/pkp/templates/images/icons/fulltext_restricted_medium.gif)
Ehrlich Ascites Carcinoma (EAC) Cells' Lipopolysaccharide as Anti-Tumour Agent against EAC Cells
Subscribe/Renew Journal
In this study we have isolated and purified lipopolysaccharide (LPS) from Ehrlich Ascites Carcinoma (EAC) cells to find its therapeutic efficacy. Each preparation was checked for homogeneity by ultra-violet spectroscopy, infra-red spectroscopy and biochemical estimations. The lipopolysaccharide thus obtained was used to observe the regression of Ehrlich Ascites Carcinoma grown in vivo. The efficacy of lipopolysaccharide was found to be dose dependent.
Keywords
Ehrlich Ascites Carcinoma Cells, Lipopolysaccharide, Cancer Chemotherapy.
Subscription
Login to verify subscription
User
Font Size
Information
![](https://i-scholar.in/public/site/images/abstractview.png)
Abstract Views: 387
![](https://i-scholar.in/public/site/images/pdfview.png)
PDF Views: 4